Insights

Market expansion Nephros is expanding beyond filtration into broader water safety solutions and education, presenting opportunities to upsell integrated water management services to healthcare facilities and commercial customers seeking comprehensive water safety programs.

Public market visibility Recent inclusion in the Russell Microcap Index and active investor events indicate rising visibility among investors and potential partners, suggesting a favorable environment for outreach to strategic buyers and collaboration opportunities with ESG-focused stakeholders.

Healthcare focus With a footprint in medical and clinical settings and emphasis on water quality for healthcare, there are sales opportunities targeting hospital systems, dialysis centers, and long-term care facilities that require reliable filtration and water management solutions.

Regulatory relevance Positioning around microplastics and Safe Drinking Water Act considerations highlights a growing compliance-driven demand that sales teams can leverage to target municipal-adjacent facilities and private water utilities seeking advanced filtration to meet regulatory expectations.

Investor and education events Upcoming virtual investor briefings and conferences provide gates for outreach to decision-makers, enabling coordinated campaigns around product efficacy, case studies, and potential pilot programs in both healthcare and commercial markets.

Similar companies to Nephros

Nephros Tech Stack

Nephros uses 8 technology products and services including SOLIDWORKS, WordPress, CookieYes, and more. Explore Nephros's tech stack below.

Media & News

Nephros's Email Address Formats

Nephros uses at least 4 email formats:
Nephros Email FormatsExamplePercentage
First@nephros.comJohn@nephros.com
43%
First.Last@nephros.comJohn.Doe@nephros.com
32%
FLast@nephros.comJDoe@nephros.com
20%
Last@nephros.comDoe@nephros.com
5%

Frequently Asked Questions

What is Nephros's phone number?

Minus sign iconPlus sign icon
You can contact Nephros's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Nephros's stock symbol?

Minus sign iconPlus sign icon
Nephros is a publicly traded company; the company's stock symbol is NEPH.

What is Nephros's official website and social media links?

Minus sign iconPlus sign icon
Nephros's official website is nephros.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Nephros generate?

Minus sign iconPlus sign icon
As of August 2026, Nephros's annual revenue is estimated to be $10M - $25M.

What is Nephros's SIC code and NAICS code?

Minus sign iconPlus sign icon
Nephros's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Nephros have currently?

Minus sign iconPlus sign icon
As of August 2026, Nephros has approximately 53 employees across 4 continents, including North America, South America and Europe. Key team members include Chief Commercial Officer (cco): W. L., Medical Director: K. S. and Independent Director: J. H. Explore Nephros's employee directory with LeadIQ.

What industry does Nephros belong to?

Minus sign iconPlus sign icon
Nephros operates in the Biotechnology Research industry.

What technology does Nephros use?

Minus sign iconPlus sign icon
Nephros's tech stack includes SOLIDWORKS, WordPress, CookieYes, Salesforce, Shopify, Microsoft 365, Google Cloud and WP Engine.

What is Nephros's email format?

Minus sign iconPlus sign icon
Nephros's email format typically follows the pattern of First@nephros.com. Find more Nephros email formats with LeadIQ.

How much funding has Nephros raised to date?

Minus sign iconPlus sign icon
As of August 2026, Nephros has raised $12M in funding. The last funding round occurred on Jul 13, 2021 for $1.2M.

When was Nephros founded?

Minus sign iconPlus sign icon
Nephros was founded in 1997.
Nephros logo

Nephros

Biotechnology ResearchNew Jersey, United States51-200 Employees

Nephros is a biotechnology company that develops water filtration technology and provides related services, along with education about water quality, as part of an integrated approach to water safety. Its offerings target healthcare and commercial customers, delivering proactive and emergency water-management solutions. Based in South Orange, New Jersey, the firm operates as a mid-sized player in the water-technology and biotechnology research space. In 2026, Nephros highlighted ultrafiltration technology as a response to emerging microplastic concerns in drinking water. The company serves healthcare facilities and commercial environments and trades on Nasdaq under the NEPH ticker, reflecting its engagement with investors while pursuing its water-technology focus.

Section iconCompany Overview

Phone number
SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
NEPH
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1997
Employees
51-200

Section iconFunding & Financials

  • $12M

    Nephros has raised a total of $12M of funding over 8 rounds. Their latest funding round was raised on Jul 13, 2021 in the amount of $1.2M as a Post IPO Equity.

  • $10M - $25M

    Nephros's revenue is estimated to be in the range of $10M - $25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.